NYSEARCA:TERM EquityCompass Tactical Risk Manager ETF (TERM) Price, Holdings, & News $22.15 +0.13 (+0.59%) As of 10/15/2021 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About EquityCompass Tactical Risk Manager ETF (NYSEARCA:TERM) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get TERM alerts:Sign Up Key Stats Today's Range$22.15▼$22.1550-Day Range$22.15▼$22.1552-Week Range$15.07▼$22.43Volume700 shsAverage Volume1,478 shsMarket Capitalization$12.18 millionAssets Under Management$12.12 millionDividend Yield1.31%Net Expense Ratio0.67%Aggregate RatingN/A ETF Overview Read More EquityCompass Tactical Risk Manager ETF ExpensesTypeTERMLong/Short ETFsMulti Asset ETFsNYSEARCA ETFsAll ETFsManagement Fee0.65%0.84%0.70%0.51%0.53%Other Expenses0.02%2.77%0.71%0.59%0.56%Total Expense0.67%2.54%1.19%0.74%0.73%Fee Waiver0.00%-3.09%-0.60%-0.71%-0.63%Net Expense0.67%1.42%0.96%0.58%0.60% Receive TERM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for EquityCompass Tactical Risk Manager ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address TERM ETF News HeadlinesLSAT: Should You Buy This High-Fee Tactical All-Cap Value ETF?June 26, 2025 | seekingalpha.comO-I GLASS TO DETAIL STRATEGIC INITIATIVES TO DRIVE LONG-TERM VALUEMarch 13, 2025 | globenewswire.comTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes. | Porter & Company (Ad)6 ETFs Focused on Gender EqualityOctober 3, 2024 | msn.comAre Covered Call ETFs a Good Investment?September 9, 2024 | msn.comConquer Risk Tactical OpportunitiesSeptember 6, 2024 | morningstar.comMSee More Headlines TERM ETF - Frequently Asked Questions How have TERM shares performed this year? EquityCompass Tactical Risk Manager ETF's stock was trading at $22.15 at the start of the year. Since then, TERM shares have increased by 0.0% and is now trading at $22.15. How do I buy shares of EquityCompass Tactical Risk Manager ETF? Shares of TERM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of EquityCompass Tactical Risk Manager ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that EquityCompass Tactical Risk Manager ETF investors own include Aldeyra Therapeutics (ALDX), Biodexa Pharmaceuticals (BDRX), Candel Therapeutics (CADL), Cleanspark (CLSK), CXApp (CXAI), DiaMedica Therapeutics (DMAC) and Dyne Therapeutics (DYN). Fund Details IssuerFirst Trust Fund NameEquityCompass Tactical Risk Manager ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:TERM Inception Date4/10/2017 Fund ManagerTimothy M. McCann, Bernard J. Kavanagh WebN/A PhoneN/AFund Focus Asset ClassMulti Asset BenchmarkN/A CategoryAbsolute Returns FocusLong/Short Development LevelDeveloped Markets RegionNorth America Number of Holdings0 Fund Statistics Assets Under Management$12.12 million Average Daily Volume$654.90 Discount/Premium-0.01% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorFirst Trust Advisors L.P. CustodianThe Bank of New York Mellon Corporation DistributorFirst Trust Portfolios L.P. Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerN/A Miscellaneous Outstanding Shares550,000BetaN/A The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free Report TERM Sector ExposureTERM Industry Exposure This page (NYSEARCA:TERM) was last updated on 8/10/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EquityCompass Tactical Risk Manager ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share EquityCompass Tactical Risk Manager ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
